APA (7th ed.) Citation

JWT, v. d. W., SM, E., M, J., D, v. d. B., SK, B., LC, S., . . . AJ, d. L. (2025). Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study. Lung cancer (Amsterdam, Netherlands), 209, 108783. https://doi.org/10.1016/j.lungcan.2025.108783

Chicago Style (17th ed.) Citation

JWT, van der Wel, et al. "Determining the Optimal Approach to Identify Osimertinib Resistance; the First Line Osimertinib Cohort of the OSIRIS Study." Lung Cancer (Amsterdam, Netherlands) 209 (2025): 108783. https://doi.org/10.1016/j.lungcan.2025.108783.

MLA (9th ed.) Citation

JWT, van der Wel, et al. "Determining the Optimal Approach to Identify Osimertinib Resistance; the First Line Osimertinib Cohort of the OSIRIS Study." Lung Cancer (Amsterdam, Netherlands), vol. 209, 2025, p. 108783, https://doi.org/10.1016/j.lungcan.2025.108783.